What is the impact of SOCS3, IL-35 and IL17 in immune pathogenesis of recurrent pregnancy loss?

References

• Witkin SS, Linhares IM, Bongiovanni AM, et al. Unique alterations in infection-induced immune activation during pregnancy. BJOG 2011;118:145–53
   PubMed Web of Science ®Google Scholar
• Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005;19:681–93
   PubMed Web of Science ®Google Scholar
• Laird SM, Tuckerman EM, Cork BA, et al. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003;9:163–74
   PubMed Web of Science ®Google Scholar
• Tilburgs T, Roelen DL, van der Mast BJ, et al. Evidence for a selective migration of fetus-specific CD4 + CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol 2008;180:5737–45
   PubMed Web of Science ®Google Scholar
• Hogge WA, Byrnes AL, Lanasa MC, Surti U. The clinical use of karyotyping spontaneous abortions. Am J Obstet Gynecol 2003;189:397–400
   PubMed Web of Science ®Google Scholar
• Christiansen OB, Nielsen HS, Kolte AM. Future directions of failed implantation and recurrent miscarriage research. Reprod Biomed Online 2006;13:71–83
   PubMed Web of Science ®Google Scholar
• Heuser C, Dalton J, Macpherson C, et al. Idiopathic recurrent pregnancy loss recurs at similar gestational ages. Am J Obstet Gynecol 2010;203:343.e1–5
   Web of Science ®Google Scholar
• Lee SK, Na BJ, Kim JY, et al. Determination of clinical cellular immune markers in women with recurrent pregnancy loss. Am J Reprod Immunol 2013;70:398–411
   PubMed Web of Science ®Google Scholar
• Hill JA, Polgar K, Anderson DJ. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995;273:1933–6
   PubMed Web of Science ®Google Scholar
• Peck A, Mellins ED. Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 2009;129:147–53
   PubMed Web of Science ®Google Scholar
• Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010;159:109–19
   PubMed Web of Science ®Google Scholar
• Whitehead GS, Wilson RH, Nakano K, et al. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 2012;129:207–15
   PubMed Web of Science ®Google Scholar
• Niedbala W, Wei XQ, Cai B, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007;37:3021–9
   PubMed Web of Science ®Google Scholar
• Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010;63:601–10
   PubMed Web of Science ®Google Scholar
• Challis JR, Lockwood CJ, Myatt L, et al. Inflammation and pregnancy. Reprod Sci 2009;16:206–15
   PubMed Web of Science ®Google Scholar
• Sykes L, MacIntyre DA, Yap XJ, et al. The Th1:Th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm 2012;2012:967629
   PubMed Web of Science ®Google Scholar
• Cemgil Arikan D, Aral M, Coskun A, Ozer A. Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. J Matern Fetal Neonatal Med 2012;25:1569–73
   PubMed Web of Science ®Google Scholar
• Toldi G, Rigó Jr J, Stenczer B, et al. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol 2011;66:223–9
   PubMed Web of Science ®Google Scholar
• Wang WJ, Hao CF, Yi Lin, et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol 2010;84:164–70
   PubMed Web of Science ®Google Scholar
• Abell K, Watson CJ. The Jak/Stat pathway: a novel way to regulate PI3K activity. Cell Cycle 2005;4:897–900
   PubMed Web of Science ®Google Scholar
• Carow B, Reuschl AK, Gavier-Widén D, et al. Critical and ındependent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis. PLoS Pathog 2013;9:e1003442
   Web of Science ®Google Scholar
• Raghupathy R, Makhseed M, Azizieh F, et al. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 2000;15:713–18
   PubMed Web of Science ®Google Scholar
• Giannubilo SR, Landi B, Pozzi V, et al. The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. Cytokine 2012;58:50–6
   PubMed Web of Science ®Google Scholar
• Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353–6
   PubMedGoogle Scholar
• Kwak-Kim JY, Chung-Bang HS, Ng SC, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003;18:767–73
   PubMed Web of Science ®Google Scholar
• Kaur A, Kaur A. Recurrent pregnancy loss: TNF-α and IL-10 polymorphisms. J Hum Reprod Sci 2011;4:91–4
   PubMedGoogle Scholar
• Palmirotta R, La Farina F, Ferroni P, et al. TNFA gene promoter polymorphisms and susceptibility to recurrent pregnancy loss in Italian women. Reprod Sci 2010;17:659–66
   PubMed Web of Science ®Google Scholar
• Liang P, Mo M, Li GG, et al. Comprehensive analysis of peripheral blood lymphocytes in 76 women with recurrent miscarriage before and after lymphocyte immunotherapy. Am J Reprod Immunol 2012;68:164–74
   PubMed Web of Science ®Google Scholar
• Calleja-Agius J, Jauniaux E, Pizzey AR, Muttukrishna S. Investigation of systemic inflammatory response in first trimester pregnancy failure. Hum Reprod 2012;27:349–57
   PubMed Web of Science ®Google Scholar
• Fischer A. Human immunodeficiency: connecting STAT3, Th17 and human mucosal immunity. Immunol Cell Biol 2008;86:549–51
   PubMed Web of Science ®Google Scholar
• Liu YS, Wu L, Tong XH, et al. Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion. Am J Reprod Immunol 2011;65:503–11
   PubMed Web of Science ®Google Scholar
• Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123–32
   PubMed Web of Science ®Google Scholar
• Naundorf S, Schröder M, Höflich C, et al. IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells. Eur J Immunol 2009;39:1066–77
   PubMed Web of Science ®Google Scholar
• Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007;450:566–9
   PubMed Web of Science ®Google Scholar
• Bettini M, Castellaw AH, Lennon GP, et al. Prevention of autoimmune diabetes by ectopic pancreatic β-cell expression of interleukin-35. Diabetes 2012;61:1519–26
   PubMed Web of Science ®Google Scholar
• Xu X, Wang Q, Deng B, et al. Monocyte chemoattractant protein-1 secreted by decidual stromal cells inhibits NK cells cytotoxicity by up-regulating expression of SOCS3. PLoS One 2012;7:e41869
   Web of Science ®Google Scholar
• Braunschweig A, Poehlmann TG, Busch S, et al. Signal transducer and activator of transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92. Am J Reprod Immunol 2011;66:329–35
   PubMed Web of Science ®Google Scholar
• Wang Y, Lewis DF, Gu Y, et al. Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia. Hypertension 2011;57:336–42
   PubMed Web of Science ®Google Scholar
• Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, et al. The expression of suppressor of cytokine signaling 1 and 3 in fat and placental tissue from women with gestational diabetes. Gynecol Endocrinol 2012;28:841–4
   PubMed Web of Science ®Google Scholar
• Zhang LJ, Li MY. Expression of suppressor of cytokine signaling 3 and its significance in human placenta with pregnant intrahepatic cholestasis. Zhonghua Fu Chan Ke Za Zhi 2010;45:406–10
   PubMedGoogle Scholar
• Cao LQ, Qu GD, Wang DM. Expression profiles of IL-10, TNF-a, and SOCS3 in placenta of pregnant women with intrahepatic cholestasis. Zhonghua Gan Zang Bing Za Zhi 2012;20:935–8
   PubMedGoogle Scholar